StockData
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd. (RDHL) stock

RDHLNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 27, 2026Score 0/30
$0.38−0.01 (-1.60%)

Close on Nov 13, 2026Market cap $1.91MP/E –Yield –

RedHill Biopharma total assets

Total assets on the balance sheet at the end of each period.

RedHill Biopharma's total assets was $26.27M at Jun 30, 2026. For fiscal 2025 it was $25.35M, up 40.5% from the year before. The highest annual figure on record is $181.19M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.35M+40.5%
FY2024Dec 31, 2024$18.04M-21.7%
FY2023Dec 31, 2023$23.05M-85.5%
FY2022Dec 31, 2022$158.87M-12.3%
FY2021Dec 31, 2021$181.19M+0.5%
FY2020Dec 31, 2020$180.24M+143.2%
FY2019Dec 31, 2019$74.10M+18.7%
FY2018Dec 31, 2018$62.41M+8.8%
FY2017Dec 31, 2017$57.34M-22.7%
FY2016Dec 31, 2016$74.21M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$26.27M+19.3%
Q4 FY2025Dec 31, 2025$25.35M+10.0%
Q2 FY2025Jun 30, 2025$18.38M-47.6%
Q4 FY2024Dec 31, 2024$18.04M-88.6%
Q2 FY2024Jun 30, 2024$22.02M-86.9%
Q4 FY2023Dec 31, 2023$23.05M-87.3%
Q2 FY2023Jun 30, 2023$35.04M-82.8%
Q4 FY2022Dec 31, 2022$158.87M-11.9%
Q2 FY2022Jun 30, 2022$167.97M+1.0%
Q4 FY2021Dec 31, 2021$181.19M+144.5%
Q2 FY2021Jun 30, 2021$203.67M+309.8%
Q4 FY2020Dec 31, 2020$180.24M+188.8%
Q2 FY2020Jun 30, 2020$166.37M+339.6%
Q4 FY2019Dec 31, 2019$74.10M+29.2%
Q2 FY2019Jun 30, 2019$49.70M-33.0%
Q4 FY2018Dec 31, 2018$62.41M–
Q2 FY2018Jun 30, 2018$37.85M–
Q4 FY2017Dec 31, 2017$57.34M–
Q4 FY2016Dec 31, 2016$74.21M–

More RedHill Biopharma figures

See a number that looks wrong?